637: DRESS SYNDROME A CUTANEOUS ADVERSE DRUG REACTION CAUSED BY VANCOMYCIN IN THE CRITICALLY ILL
Donald W. Johnson,S. Chhangani
DOI: https://doi.org/10.1097/01.CCM.0000528652.59061.4C
Abstract:Critical Care Medicine • Volume 46 • Number 1 (Supplement) www.ccmjournal.org Learning Objectives: Severe cutaneous adverse drug reactions (SCARs) are uncommon in the intensive care unit (ICU). In this report we describe drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, a rare, but potentially lethal SCAR with multi-organ failure caused by vancomycin. Methods: A 67-year-old male with hypertension, type-2 diabetes mellitus, and COPD presented to the ICU with sepsis due to necrotizing soft-tissue infection in the flank area. Following initial resuscitation and initiation of broad-spectrum antibiotics, he underwent incision and drainage of the necrotizing deep soft-tissue infection. The culture grew methicillin resistant Staphylococcus aureus and antimicrobial therapy was changed to vancomycin. After resolution of sepsis and satisfactory debridement of the wound, he was transferred to the ward with negative-pressure wound device on post-operative day (POD) 5. He underwent serial debridements of the wound and pharmacokinetic monitoring of vancomycin. On POD 12, he became febrile and lethargic and developed hypotension, oliguria, and hypercarbic respiratory failure. The physical examination showed diffuse, blanching erythematous pruritic rash on the legs. The laboratory abnormalities included leukocytosis with eosinophilia, elevated transaminases, BUN, creatinine, and supratherapeutic vancomycin level. Noninvasive ventilation support and fluid resuscitation was started. Vancomycin was changed to linezolid for ongoing MRSA coverage. Over the next day, the rash became fiery red and maculopapular in nature and progressed to involve upper extremities and trunk. Oral mucosa, palms and soles were spared. A full thickness skin biopsy was obtained under local anesthesia from leg eruptions. The presence of constellation of fever, skin rash, multiorgan involvement and eosinophilia, and a RegiSCAR score of 6 strongly favored DRESS syndrome. Prednisone was started and tapered over 10 days. Within 72-hrs of steroid therapy, there was significant resolution of rash and multi-organ failure. The skin biopsy showed acantholysis with intraepidermal blister formation and perivascular inflammation. Results: Of all SCARs, the diagnosis of DRESS syndrome is challenging. The postulated pathogenetic mechanisms underlying DRESS syndrome include genetic predisposition, defective drug metabolism, and viral reactivation. Prompt recognition of the syndrome, institution of steroid therapy and withdrawal of the culprit drug is essential in this potentially lethal condition.
Medicine